CAS 84808-64-0

Oxycyte

Description:

Oxycyte, with the CAS number 84808-64-0, is a perfluorocarbon (PFC) compound primarily known for its use in medical applications, particularly as an oxygen carrier in therapeutic settings. It is characterized by its ability to dissolve significant amounts of oxygen and carbon dioxide, making it a potential candidate for use in conditions where oxygen delivery is compromised. Oxycyte is a clear, colorless liquid that is chemically stable and non-toxic, which enhances its suitability for intravenous administration. Its unique properties allow it to facilitate oxygen transport in the bloodstream, potentially improving tissue oxygenation in hypoxic conditions. Additionally, Oxycyte is being investigated for its applications in treating conditions such as traumatic brain injury and other ischemic events. However, its use is subject to ongoing research to fully understand its efficacy and safety profile in clinical settings. Overall, Oxycyte represents a significant advancement in the field of oxygen therapeutics, with promising implications for patient care.

Formula: C₁₀F₂₀

InChI: InChI=1S/C10F20/c11-2(1(8(22,23)24,9(25,26)27)10(28,29)30)3(12,13)5(16,17)7(20,21)6(18,19)4(2,14)15

InChI key: InChIKey=VLTXBOGHSBHSAC-UHFFFAOYSA-N

SMILES: C(C(F)(F)F)(C(F)(F)F)(C(F)(F)F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F

Synonyms:

• Cyclohexane, 1,1,2,2,3,3,4,4,5,5,6-undecafluoro-6-[2,2,2-trifluoro-1,1-bis(trifluoromethyl)ethyl]-
• Cyclohexane, undecafluoro[2,2,2-trifluoro-1,1-bis(trifluoromethyl)ethyl]-
• Oxycyte
• 1,1,2,2,3,3,4,4,5,5,6-Undecafluoro-6-[2,2,2-trifluoro-1,1-bis(trifluoromethyl)ethyl]cyclohexane
• Perfluoro(1,1-dimethylethyl)cyclohexane

Perfluoro[(tert-butyl)cyclohexane]

CAS: 84808-64-0

Perfluoro[(tert-butyl)cyclohexane]

Formula: C₁₀F₂₀

Purity: ≥95%

Color and Shape: clear liquid

Molecular weight: 500.08g/mol

Ref: 54-PC49620

Perfluoro[(tert-butyl)cyclohexane]

Controlled Product

CAS: 84808-64-0

Perfluoro[(tert-butyl)cyclohexane] is a small molecule with a molecular weight of 598.3 g/mol. It has been shown to have an anticoagulant effect in animals, which is most likely due to its ability to inhibit the enzyme serine protease. In vitro studies show that this compound inhibits oxygen transport and causes cellular damage in eye tissue, which may be due to its ability to cross the blood-brain barrier. This compound also induces an acute ischemic event in rats, which was found to be mediated by inhibition of p450 activity and the subsequent reduction of oxygen transport.

Formula: C₁₀F₂₀

Purity: Min. 95%

Molecular weight: 500.07 g/mol

Ref: 3D-JDA80864